The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease ...

A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared ...

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...

The administration said it is fast-tracking clinical trials that would allow patients struggling with serious mental health ...

Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...

Avalyn Pharma has drawn in another fundraising round, this time a $100 million oversubscribed series D to continue developing ...

One of the most common misconceptions I hear is that trials are only for people who are seriously ill. In reality, healthy ...

A new immunotherapy trial for the deadliest form of brain cancer, glioblastoma, is now recruiting patients after one ...

Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken ...

Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.